Jia-Qi Lin

Research Advances and Future Directions of Biotechnology in the Treatment of Myasthenia Gravis

Myasthenia gravis (MG) is an autoimmune disease with a core pathological mechanism involving specific attacks by the immune system on proteins at the neuromuscular junction. This study reveals that our understanding of its pathogenesis has expanded beyond mere neuromuscular transmission dysfunction to encompass multipl...